Femasys (FEMY) Non-Current Assets (2020 - 2026)
Femasys' (FEMY) quarterly Non-Current Assets came in at $2.1 million in Q2 2026, down 13.63% on a YoY basis from $2.4 million in Q2 2025, and down 5.8% quarter-over-quarter from $2.2 million in Q1 2026.
Analysis
Femasys (FEMY) Non-Current Assets (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Non-Current Assets for 7 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 13.63% year-over-year to $2.1 million; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (down 13.63% YoY), and the FY2025 full-year result was $2.4 million, down 16.07% from the prior year.
- Non-Current Assets slipped to $2.1 million in Q2 2026 per FEMY's latest filing, from $2.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.5 million in Q3 2023 and bottomed at $1.0 million in Q2 2023.
- Historically, Non-Current Assets has averaged $2.2 million across 5 years, with a median of $2.3 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 199.68% in 2024, then declined 21.49% in 2025.
- Over 5 years, Non-Current Assets stood at $1.3 million in 2022, then surged by 170.63% to $3.5 million in 2023, then declined by 18.47% to $2.8 million in 2024, then decreased by 16.07% to $2.4 million in 2025, then declined by 11.54% to $2.1 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2.1 million, $2.2 million, and $2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 2.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | 2.57 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.22 Mn |